Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania

    Access Status
    Fulltext not available
    Authors
    Bista, D.
    Chalmers, Leanne
    Peterson, G.
    Bereznicki, L.
    Date
    2017
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Bista, D. and Chalmers, L. and Peterson, G. and Bereznicki, L. 2017. Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania. Clinical and Applied Thrombosis/Hemostasis. 23 (5): pp. 438-444.
    Source Title
    Clinical and Applied Thrombosis/Hemostasis
    DOI
    10.1177/1076029615623375
    ISSN
    1076-0296
    School
    School of Pharmacy
    URI
    http://hdl.handle.net/20.500.11937/58636
    Collection
    • Curtin Research Publications
    Abstract

    © 2017 SAGE Publications. Limited data are available on atrial fibrillation (AF) and its clinical management and outcomes from an Australian perspective. This study was designed to examine the patient characteristics and antithrombotic treatment patterns among patients with AF in Tasmania, Australia. This retrospective observational study reviewed and followed patients with AF admitted to Tasmania's 3 major hospitals between January 2011 and June 2012. Patients were excluded if they had only 1 episode of AF that reverted spontaneously or upon cardioversion without any documented recurrences. We reviewed the records of 2502 patients (=18 years), and1469 were subsequently included in the study. The mean (±standard deviation [SD]) age of the patients was 76 (±12.3) years. The mean (± SD) CHADS 2 score was 2.1 (±1.3), and 65.7% had a score =2. In total, only 55.6% of patients with CHADS 2 score =2 were receiving anticoagulation and 9.9% were not receiving any antithrombotic treatment, whereas 85.4% of those at low risk (score 0) were on antithrombotic therapy. Hospitalization was associated with a significant increase in the rate of combination (antiplatelet plus anticoagulant) therapy (P < .001). Suboptimal use of antithrombotic therapy highlights the need to improve AF management in our jurisdiction.

    Related items

    Showing items related by title, author, creator and subject.

    • The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
      Alamneh, E.; Stafford, Leanne; Bereznicki, L. (2017)
      © 2017 John Wiley & Sons Ltd Introduction: Contemporary Australian data regarding antithrombotic prescribing patterns following approval of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) ...
    • Evidence-to-practice gaps in the management of community-dwelling Australian patients with ischaemic heart disease
      Schmid, O.; Stafford, Leanne; Bereznicki, L. (2015)
      © 2015 John Wiley & Sons Ltd.Summary What is known and objective Ischaemic heart disease (IHD) is a major cause of death in developed countries. Patients with IHD are at greater risk of subsequent myocardial infarction ...
    • Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
      Fauchier, L.; Greenlaw, N.; Ferrari, R.; Ford, I.; Fox, K.; Tardif, J.; Tendera, M.; Steg, P.; Sokn, F.; Reid, Christopher; Lang, I.; Van Den Branden, F.; César, L.; Mattos, M.; Luqman, H.; Goudev, A.; Dorian, P.; Hu, D.; Widimsky, P.; Hassager, C.; Danchin, N.; Kääb, S.; Vardas, P.; Sulaiman, K.; Al Mahmeed, W.; Al Suwaidi, J.; Al Rashdan, I.; Abdulkader, F.; Merkely, B.; Kaul, U.; Daly, K.; Tavazzi, L.; Jang, Y.; Erglis, A.; Laucevicius, A.; Jamaluddin, A.; Gamba, M.; Tulevski, I.; Stepinska, J.; Morais, J.; Macarie, C.; Oganov, R.; Shalnova, S.; Al-Zaibag, M.; Hou, M.; Kamensky, G.; Fras, Z.; Kanic, V.; Naidoo, D.; Zamorano, J.; Rickli, H.; Jaussi, A.; Sriratanasathavorn, C.; Kalra, P.; Lutai, M.; Oleksandr; Nguyen, L.; Henry, R. (2015)
      © 2015 Fauchier et al. Background: Few data are available regarding the use of antithrombotic strategies in coronary artery disease patients with atrial fibrillation (AF) in everyday practice. We sought to describe the ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.